April 23-24, 1998 • Ramada Inn • Bethesda, Maryland Co-Sponsored by the National Institute on Alcohol Abuse and Alcoholism and the Office of Research on Women’s Health, National Institutes of Health, and the Interagency Coordinating Committee on Fetal Alcohol Syndrome Contents Speakers Agenda Introduction Background Overview of FAS Early Studies on Prevention of Alcohol Use in Pregnancy: Lessons Learned Smoking...

As a federal agency, NIAAA works continually to uphold the values of responsible stewardship, research integrity, and public trust. These values are reinforced by NIAAA’s commitment to optimal management and accountability, strategic collaboration, and communication of research results. Objective 1: Ensuring Optimal Management and Accountability NIAAA strives to continually optimize operations across its administrative and scientific functions through sound, data-driven...

A Wearable Alcohol Biosensor - A Second Challenge We would be remiss if we didn’t recognize that this Challenge is just that, a challenge. We are aware that the criteria may be difficult to meet on all accounts. However, that is why we have posted the challenge. All submissions will be judged based upon how much the solution meets all...

The below resources provide information on treatment, support, and mental and physical health for middle schoolers, as well as additional resources for school projects. Tips for Parents Quick tips on getting started with talking to your middle schooler about alcohol. Mental Health Emergencies Many young people who drink also struggle with other substance use disorders and mental health issues, such...

The following are the NIAAA divisions that support extramural basic and clinical research: Division of Epidemiology and Prevention Research Director: Dr. Ralph Hingson The Division of Epidemiology and Prevention Research (DEPR) promotes and supports applied, translational, and methodological research on the epidemiology and prevention of hazardous alcohol consumption and related behaviors, alcohol use disorder, alcohol-related mortality and morbidity, and other...

A Clinician's Guide to help patients who drink too much and other related professional support resources.

NIAAA Protocol NCIG 003: A Phase 2, Double-Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence Study Details This double-blind, randomized placebo-controlled trial evaluated the efficacy and safety of varenicline tartrate for the treatment of alcohol use disorder (AUD). Sponsor: The National Institute on Alcohol Abuse and Alcoholism’s Clinical Investigations Group (NCIG) NCT #: 01146613...

Meeting of the Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders National Institute on Alcohol Abuse and Alcoholism 5635 Fishers Lane ♦ Terrace Level Conference Center, Rockville, Maryland 20852 https://videocast.nih.gov Wednesday, April 25, 2018 AGENDA 8:30 A.M. Welcome, Introductions, and Comments Kenneth R. Warren, Ph.D., Senior Advisor, NIAAA, NIH; ICCFASD Chairperson 8:50 A.M. Overview of ICCFASD Mission and Goals Marcia...

DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM AGENDA 151st Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM Tuesday, May 14, 2019 6700 B Rockledge Drive, Bethesda, MD 20817 Webcast Open Session May 14, 2019 09:50 AM - 3:00 PM: OPEN TO THE PUBLIC 09:50 CALL TO ORDER...

TRENDS IN ALCOHOL-RELATED FATAL TRAFFIC CRASHES, UNITED STATES, 1982–2004 Hsiao-ye Yi, Ph.D. Chiung M. Chen, M.A. Gerald D. Williams, D.Ed. CSR, Incorporated 1 Suite 1000 2107 Wilson Boulevard Arlington, VA 22201 August 2006 U.S. Department of Health and Human Services Public Health Service National Institutes of Health 1 CSR, Incorporated, operates the Alcohol Epidemiologic Data System (AEDS) under Contract No...

51.2% alcohol psychosis 27.1% chronic liver disease and cirrhosis 15.9% alcohol dependence syndrome 4.2% nondependent abuse of alcohol 1.6% alcohol poisoning Total number of discharges with principal (first-listed) mention of an alcohol-related diagnosis = approximately 412,000

TRENDS IN SUBSTANCE USE AMONG REPRODUCTIVE-AGE FEMALES IN THE UNITED STATES, 2002–2015 Megan E. Slater, Ph.D. Sarah P. Haughwout, M.P.H. CSR, Incorporated 1 4250 N. Fairfax Drive Suite 500 Arlington, VA 22203 September 2017 U.S. Department of Health and Human Services Public Health Service National Institutes of Health 1 CSR, Incorporated operates the Alcohol Epidemiologic Data System (AEDS) under Contract...

This article was first published in NIAAA Spectrum Volume 14, Issue 2. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer Research (STTR) program supports the development and commercialization of innovative tools, technologies, and strategies. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) SBIR/STTR program aims to improve the diagnosis, prevention, and treatment—as well as recovery from—alcohol-related...

NIAAA Protocol NCIG 006: A Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of HORIZANT® (Gabapentin Enacarbil) Extended-Release Tablets for the Treatment of Alcohol Use Disorder Study Details This large, multisite clinical trial evaluated the efficacy and safety of gabapentin enacarbil extended-release (GE-XR) (HORIZANT®), a gabapentin prodrug formulation for the treatment of alcohol use disorder (AUD). Sponsor: The...

Kathy Jung, Ph.D. February 09, 2023 Purpose The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue the Alcohol-associated hepatitis (AH) research program, a multi-center translational and clinical network (AlcHepNet), established in 2012 with renewal in 2018. The goal of AlcHepNet is to accelerate the discovery and validation of new diagnostic and treatment options for patients with severe...

Thursday, April 13, 2017 National Institute on Alcohol Abuse and Alcoholism 5635 Fishers Lane, Terrace Level Conference Center, Rockville, Maryland Meeting Summary Download Print Version (104 KB): Contents Welcome, Introductions, and Comments Overview of ICCFASD Mission and Goals Update from the DOJ and the ICCFASD Justice Issues Work Group Reports of Activities of the ICCFASD Agencies: SAMHSA, NIAAA, and NIDA...

With sadness, NIAAA shares the news of the death of John M. Littleton, M.D., Ph.D., on May 1, 2023. Dr. Littleton's groundbreaking research contributed to our understanding of the development of functional tolerance to alcohol, the role of L-type Ca2+ channels in the physiology of alcohol actions, alcohol-nicotine interactions at the behavioral and cellular levels, and the use of mammalian...

This 28-day treatment program aimed to prevent incarcerated first-time offenders from repeated instances of driving under the influence of alcohol by providing individual counseling, group treatment, and post-discharge monitoring.

May 2019 Primary Representatives ICCFASD Chairperson Patricia A. Powell, Ph.D. Deputy Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 6700B Rockledge Drive, Room 1207, MSC 6902 Bethesda, MD 20892- 6902 Phone: 301-443-5106 E-mail: [email protected] For deliveries: 6700B Rockledge Drive, Bethesda, MD 20817 ICCFASD Scientific Coordinator and Executive Secretary Tatiana Balachova, Ph.D. Health Scientist Administrator Division of...

The ICCFASD and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), sponsor and chair of ICCFASD, invited input on the draft outline of the ICCFASD new strategic plan from diverse stakeholders, including scientific experts, health care providers, patients and family members, advocacy groups, other federal agencies, and non-governmental scientific, professional, and healthcare organizations. Organizations were encouraged to submit a...